biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 29, 2016 5:35pm

136 Views

Post# 24606777

RE:and back down to $1.11

and back down to $1.11 but this time on volume. Geez, when is this thing gonna gain traction on the upside.

The easiest, most predictable stock move in the known universe: Buy the rumour, sell the news.

Not sure what to make of RBC being both on the buy and sell side today.

RBC has 10s of thousands of brokerage customers. Some of them bought today, some of them sold.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!